德国前瞻性队列:筛查结肠镜大幅降低结直肠癌发病与死亡
该研究基于德国萨尔兰州9207名50-75岁无结直肠癌史参与者的前瞻性队列,分析筛查结肠镜与结直肠癌发病及死亡的关系。中位随访17.2年,筛查结肠镜与总体发病(aHR 0.44)和死亡(aHR 0.34)显著降低相关,远端癌降低更明显,近端癌死亡在10年内也显著降低。
要点
- 远端癌发病和死亡降低更显著,近端癌死亡10年内也降低。
核心结论
- 筛查结肠镜与结直肠癌发病和死亡的大幅降低相关。
研究设计与样本
- 德国萨尔兰州前瞻性队列研究,纳入9207名50-75岁无结直肠癌史参与者,基线为2000-2002年,随访至2018年。
主要发现
- 中位随访17.2年,268人诊断为结直肠癌,98人死于结直肠癌。
- 筛查结肠镜与总体发病降低相关(aHR 0.44,95%CI 0.33-0.57)。
- 筛查结肠镜与总体死亡降低相关(aHR 0.34,95%CI 0.21-0.53)。
- 远端癌发病aHR 0.36(95%CI 0.25-0.51),死亡aHR 0.33(95%CI 0.19-0.59)。
- 近端癌发病aHR 0.69(95%CI 0.42-1.13),死亡aHR 0.62(95%CI 0.26-1.45);筛查后10年内近端癌死亡aHR 0.31(95%CI 0.10-0.96)。
临床怎么用
- 支持将筛查结肠镜作为降低结直肠癌发病和死亡的有效手段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: A claimed advantage of colonoscopy over sigmoidoscopy in colorectal cancer (CRC) screening is prevention of CRC not only in the distal colon and rectum but also in the proximal colon. We aimed to assess the association of screening colonoscopy use with overall and site-specific CRC incidence and associated mortality. METHODS: Information on use of screening colonoscopy as well as potential confounding factors was obtained at baseline in 2000-2002, updated at 2-, 5-, 8-, and 17-year follow-up from 9,207 participants aged 50-75 years without history of CRC in a statewide cohort study in Saarland, Germany. Covariate-adjusted associations of screening colonoscopy with CRC incidence and mortality, which were obtained through record linkage with the Saarland Cancer Registry and mortality statistics up to 2018, were assessed by Cox proportional hazards models with time-varying exposure information. RESULTS: During a median follow-up of 17.2 years, 268 participants were diagnosed with CRC and 98 died from CRC. Screening colonoscopy was associated with strongly reduced CRC incidence (adjusted hazard ratio [aHR] 0.44, 95% confidence interval [CI] 0.33-0.57) and mortality (aHR 0.34, 95% CI 0.21-0.53), with stronger reduction for distal (aHRs 0.36, 95% CI 0.25-0.51, and 0.33, 95% CI 0.19-0.59, respectively) than for proximal cancer (aHRs 0.69, 95% CI 0.42-1.13, and 0.62, 95% CI 0.26-1.45, respectively). Nevertheless, strong reduction of mortality from proximal cancer was also observed within 10 years after screening colonoscopy (aHR 0.31, 95% CI 0.10-0.96). DISCUSSION: In this large prospective cohort study from Germany, screening colonoscopy was associated with strong reduction in CRC incidence and mortality.
引用
- Guo F, Chen C, Holleczek B, et al. Strong Reduction of Colorectal Cancer Incidence and Mortality After Screening Colonoscopy: Prospective Cohort Study From Germany. Am J Gastroenterol. 2021. PMID: 33929378. doi:10.14309/ajg.0000000000001146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。